AQST
Aquestive Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.02
-0.01 ▼ -0.25%
🌙 3월 13일 7:05 PM ET (한국 3/14 08:05)
$4.05
+0.03 ▲ +0.75%
| Index | RUT | P/E | - | EPS (ttm) | -0.78 | Insider Own | 5.68% | Shs Outstand | 0.12B | Perf Week | -4.74% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | 3% | Insider Trans | -7.91% | Shs Float | 0.12B | Perf Month | 5.24% |
| Enterprise Value | 0.50B | PEG | - | EPS next Q | -0.13 | Inst Own | 56.86% | Short Float | 17.33% | Perf Quarter | -35.47% |
| Income | -0.08B | P/S | 11.01 | EPS this Y | 40.03% | Inst Trans | 5.53% | Short Ratio | 4.06 | Perf Half Y | -18.79% |
| Sales | 0.04B | P/B | - | EPS next 5Y | 30.66% | ROA | -63.57% | Short Interest | 19.95M | Perf YTD | -37.77% |
| Book/sh | -0.28 | P/C | 4.05 | EPS past 3/5Y | 11.13% 13.92% | ROE | - | 52W High | -46.75% ($7.55) | Perf Year | 47.79% |
| Cash/sh | 0.99 | P/FCF | - | Sales past 3/5Y | -2.24% -0.58% | ROIC | -97.24% | 52W Low | 89.62% ($2.12) | Perf 3Y | 411.58% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -50.14% | Gross Margin | 58.35% | Volatility(W/M) | 5.03% 5.45% | Perf 5Y | -24.29% |
| Dividend TTM | - | EV/Sales | 11.24 | Sales Y/Y TTM | -22.61% | Oper. Margin | -159.5% | ATR (14) | 0.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.01 | EPS Q/Q | -39.68% | Profit Margin | -188.09% | RSI (14) | 47.06 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.14 | Sales Q/Q | 9.67% | SMA20 | -1.43% ($4.08) | Beta | 1.57 | Target Price | $8.89 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -2.1% ($4.11) | Rel Volume | 0.34 | Prev Close | $4.03 |
| Employees | 147 | LT Debt/Eq | - | EPS/Sales Surpr. | -100% -2.04% | SMA200 | -15.32% ($4.75) | Avg Volume(3M) | 4.92M | Price | $4.02 |
| IPO | 2018/7/25 | Option/Short | Yes/Yes | Trades | 7277 | Volume | 1,662,732 | Change | -0.25% |
뉴스 로딩 중...